Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.16

-$0.15 (-4.53%)

At close: Oct 30, 2026, 3:59 PM ET

$3.16

$0.00 (0.00%)

After-hours: Oct 30, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $27.22M

Enterprise Value $15.5M

Beta 4.20

Average Volume 16.72K

Shares Outstanding (Diluted) 11.07M

Shares Change YoY 50.35%

Institutional Ownership N/A

Exchange AMEX

ISIN IL0012181553

Price Performance

Price Change 1M -14.4%

Price Change 3M 4.3%

Price Change 6M 14.9%

Price Change YTD -65.5%

Price Change 1Y -59.4%

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -13.0%

1Y CAGR (ann.) -60.4%

5Y CAGR (ann.) N/A

All-Time CAGR -55.7%

Valuation

PE Ratio -3.29

Forward PE N/A

PEG Ratio 0.03

Forward PEG -0.05

PS Ratio N/A

Forward PS N/A

PB Ratio 2.48

P/FCF Ratio -8.09

P/Adj. FCF Ratio -8.09

P/OCF Ratio -10.53

EV/Sales N/A

EV/EBIT -1.52

EV/EBITDA -2.16

EV/FCF -4.61

Earnings Yield -30.4%

FCF Yield -12.4%

Adj. FCF Yield -12.4%

Financial Health

Net Cash $11.82M

Total Debt $103K

Cash & Short-Term Investments $11.82M

Total Assets $12.45M

Current Ratio 8.77

Quick Ratio 8.77

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.03

OCF / Debt -32.60

Interest Coverage 0.00

Altman Z-Score 6.51

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) 0.0%

Returns

Return on Assets -87.8%

Return on Equity -158.8%

Return on Invested Capital -96.5%

Return on Capital Employed -96.9%

Return on Tangible Assets -87.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -76.6%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -144.7%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 42.7%

Revenue Growth Next 3Y N/A

Earnings Date Mar 3, 2027

EPS Estimate (next Q) -$0.73

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $22.00

Price Target Upside 596.2%

Cash Flow

Operating Cash Flow $-3.36M

Free Cash Flow $-3.36M

Adj. Free Cash Flow $-3.36M

FCF Per Share -$0.30

OCF Per Share -$0.30

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-10.3M

EBITDA $-7.18M

Net Income $-10.3M

EPS (Diluted) -$0.96

Revenue / Employee N/A

Profit / Employee $-1.47M

Employees 7